BeOne Share Price

BeOne Share Price

NASDAQ: ONC | Mega Cap | Healthcare
$403.55
-$9.56 (-2.31%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

BeOne Stock Performance

Open
$408.05
Prev. Close
$413.11
Circuit Range
N/A
Day Range
$402.90 - $409.08
Year Range
$253.96 - $424.66
Volume
11,738
Average Traded
$405.22

BeOne Share Price Today

As of 19 November 2026, BeOne Medicines Ltd.'s share price is $403.55. The stock opened at $408.05, compared to its previous close of $413.11. During today's trading session, BeOne Medicines Ltd.'s share price traded between $402.90 and $409.08, with an average price of $405.99. Over the past 52 weeks, the stock has recorded a high of $424.66 and a low of $253.96. In terms of performance, BeOne Medicines Ltd.'s share price has risen by 40.24% over the last six months and is up 18.37% on a year-on-year basis.

BeOne Share Price Chart

Line chart of the BeOne price trend over the selected period. The price fell overall, ranging from 402.90 to 409.08, ending at 403.55.
$402.90$409.08
L
Show Current Price
H

BeOne Stock Fundamentals & Key Indicators

Market Cap
$572.15B
PE Ratio (TTM)
51.56
Dividend Yield
0.00%
EPS (TTM)
$8.02
Revenue (TTM)
$5.34T
Return On Equity (TTM)
15.73%
Profit Margin
5.37%
Debt to Equity
0.18
Quarterly Earnings Growth YoY
478.51%

BeOne Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1498.17$1513.44$1705.07$1889.82
Net Profit$66.50$227.36$237.01$384.71
Net Profit Margin4.44%15.02%13.90%20.36%
Income ChangeN/A241.89%4.24%62.32%

BeOne Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$5343.03
Net Profit$286.93
Net Profit Margin5.37%
Income ChangeN/A

BeOne Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets1954.98
Current Assets6233.59
Total Assets8188.57
Non Current Liabilities1998.55
Current Liabilities1828.83
Total Liabilities3827.38
Shareholders' Equity4361.19

BeOne Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating1,127.58
Investing-276.16
Financing1,059.45

About BeOne

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes mainly with AbbVie and AstraZeneca. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

BeOne Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$366.44
$403.57
+9.02%
Oct 2026
$368.41
$370.17
+1.13%
Sep 2026
$351.40
$366.04
-1.76%
Aug 2026
$314.00
$372.58
+17.93%
Jul 2026
$285.00
$315.92
+10.80%
Jun 2026
$284.56
$285.13
-0.91%
May 2026
$293.89
$287.76
-2.49%
Apr 2026
$307.03
$295.10
-0.60%
Mar 2026
$305.50
$296.87
-6.27%
Feb 2026
$332.48
$316.75
-6.93%
Jan 2026
$308.04
$340.34
+12.03%
Dec 2025
$339.19
$303.81
-10.89%

BeOne Share Price FAQs